News

Video

Breaking Down Misconceptions About Glioblastoma

David Reardon, M.D., clinical director at the Center for Neuro-oncology at the Dana-Farber Cancer Institute, breaks down a common misconception that many people have about glioblastoma (GBM).

David Reardon, M.D., clinical director at the Center for Neuro-oncology at the Dana-Farber Cancer Institute, breaks down a common misconception that many people have about glioblastoma (GBM).

When people hear about a GBM diagnosis, their first thoughts might be that there is little to no hope in treating the disease. However, recent scientific advances continue to improve outcomes for people with GBM. For example, a SurVaxM, an agent that harnesses the body’s immune system to fight the cancer, has shown promising results in trials and was granted an Orphan Drug Status by the Food and Drug Administration (FDA) in early August. Other immunotherapy agents are also in the pipeline.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Clinical Trial Evaluating Monjuvi in Lymphoma Gives Lasting Responses
Survivors can find strength after cancer by focusing on goals, loved ones, and spiritual connection, especially during challenging or uncertain times.
Image of man with text.
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses
Mark Daniels, an 83-year-old veteran and former fighter pilot, was shocked by his lymphoma diagnosis because he maintained exceptional physical fitness.
Image of man with text.
Image of women, with text.
Image of Dr. with text.
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.